Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to 15.39%.

  • Orthopediatrics' EBIT Margin fell 51900.0% to 15.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.84%, marking a year-over-year decrease of 45400.0%. This contributed to the annual value of 17.1% for FY2024, which is 8900.0% up from last year.
  • Orthopediatrics' EBIT Margin amounted to 15.39% in Q3 2025, which was down 51900.0% from 17.45% recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' EBIT Margin ranged from a high of 10.2% in Q3 2024 and a low of 27.83% during Q1 2021
  • In the last 5 years, Orthopediatrics' EBIT Margin had a median value of 19.92% in 2022 and averaged 18.84%.
  • As far as peak fluctuations go, Orthopediatrics' EBIT Margin surged by 449300bps in 2021, and later plummeted by -67200bps in 2025.
  • Over the past 5 years, Orthopediatrics' EBIT Margin (Quarter) stood at 22.41% in 2021, then fell by -20bps to 26.81% in 2022, then grew by 20bps to 21.44% in 2023, then dropped by -24bps to 26.69% in 2024, then skyrocketed by 42bps to 15.39% in 2025.
  • Its EBIT Margin stands at 15.39% for Q3 2025, versus 17.45% for Q2 2025 and 20.95% for Q1 2025.